The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Penetration Enhancers and Ocular Bioadhesives: Two New Avenues for Ophthalmic Drug Delivery
Abstract
This review is focused on the two avenues of development that promise a major impact on future ocular drug therapeutics: bioadhesives, including hydrogels and other agents like carbopols, polyacrylic acids, chitosan, etc., and penetration enhancers, including different surfactants, calcium chelators, etc. The capacity of some polymers to adhere to the mucin coat covering the conjunctiva and the corneal surface of the eye forms the basis for ocular mucoadhesion. These systems markedly prolong the residence time of a drug in the conjunctival sac, since clearence is now controlled by the much slower rate of mucus turnover rather than the tear turnover rate. But improving the corneal drug retention alone is inadequate in bringing about a significant improvement of drug bioavailability. Another approach consists of transiently increasing the pentration characteristics of the cornea with appropriate substances, known as penetration enhancers or absorption promoters. The main aim of this article is to give an insight into the potential application of mucoadhesives and corneal penetration enhancers for the conception of innovative opthalmic delivery appraoches, to decrease the systemic side effects, and create a more focused effect, which may be achieved with lower doses of the drug. Ophthalmic formulations based on these mucoadhesives and penetration enhancers are simple to manufacture and exhibit an excellent tolerance when administered into the cornea. The use of the former considerably prolongs the corneal contact time and the use of the latter increases the rate and amount of drug transport. The various corneal epithelial barriers along with the major routes of transport of drugs are discussed. The article includes a list of the various substances in use or under investigation for the aforementioned properties, along with their mechanisms of action. A fair appraisal of the subject with regard to these two therapeutic approaches and any expected ill effects has been made.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Encyclopedia of Pharmaceutical Technology
Swarbrick, J. (2013) · CRC Press eBooks · doi:10.1201/b19309 · Cited by 1,794
In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers
Lehr, C.-M., Bouwstra, J. A., Schacht, E. H., & Junginger, H. E. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90353-4 · Cited by 1,035
Physiological function of connective tissue polysaccharides.
Comper, W. D., & Laurent, T. C. (1978) · Physiological Reviews · doi:10.1152/physrev.1978.58.1.255 · Cited by 991
Chandy, T., & Sharma, C. P. (1990) · Biomaterials, Artificial Cells and Artificial Organs · doi:10.3109/10731199009117286 · Cited by 757
Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues
Peppas, N. A., & Buri, P. A. (1985) · Journal of Controlled Release · doi:10.1016/0168-3659(85)90050-1 · Cited by 710
Hirano, S. (2002) · Ullmann's Encyclopedia of Industrial Chemistry · doi:10.1002/14356007.a06_231 · Cited by 562
Structure, biochemistry, and assembly of epithelial tight junctions
Gumbiner, B. (1987) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1987.253.6.c749 · Cited by 531
Topical Ocular Drug Delivery: Recent Developments and Future Challenges
LEE, V. H. L., & ROBINSON, J. R. (1986) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.1986.2.67 · Cited by 503
Flanagan, M. D., & Lin, S. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86105-7 · Cited by 433
Bioadhesive polymers as platforms for oral-controlled drug delivery: method to study bioadhesion
Park, K., & Robinson, J. R. (1984) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(84)90154-6 · Cited by 420
Cited by
Chitosan-based hydrogels for controlled, localized drug delivery
Bhattarai, N., Gunn, J., & Zhang, M. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.07.019 · Cited by 2,451
The use of mucoadhesive polymers in ocular drug delivery
LUDWIG, A. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.07.005 · Cited by 922
Hyaluronic Acid: Redefining Its Role
Abatangelo, G., Vindigni, V., Avruscio, G., Pandis, L., & Brun, P. (2020) · Cells · doi:10.3390/cells9071743 · Cited by 533
Vesicular systems in ocular drug delivery: an overview
Kaur, I. P., Garg, A., Singla, A. K., & Aggarwal, D. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.09.016 · Cited by 450
Self-citationSparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery
Gupta, H., Aqil, M., Khar, R. K., Ali, A., Bhatnagar, A., & Mittal, G. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.10.004 · Cited by 367
Chitosan-based nanostructures: A delivery platform for ocular therapeutics
de la Fuente, M., Raviña, M., Paolicelli, P., Sanchez, A., Seijo, B., & Alonso, M. J. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.026 · Cited by 354
The potential of chitosan in ocular drug delivery
Alonso, M. J., & Sánchez, A. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357022476 · Cited by 352
Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases
Onugwu, A. L., Nwagwu, C. S., Onugwu, O. S., Echezona, A. C., Agbo, C. P., Ihim, S. A., Emeh, P., Nnamani, P. O., Attama, A. A., & Khutoryanskiy, V. V. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.018 · Cited by 350
Liposomes as an ocular delivery system for acetazolamide: In vitro and in vivo studies
Hathout, R. M., Mansour, S., Mortada, N. D., & Guinedi, A. S. (2007) · AAPS PharmSciTech · doi:10.1208/pt0801001 · Cited by 346
Hyaluronan: Pharmaceutical Characterization and Drug Delivery
Liao, Y.-H., Jones, S. A., Forbes, B., Martin, G. P., & Brown, M. B. (2005) · Drug Delivery · doi:10.1080/10717540590952555 · Cited by 342
Niosome-Encapsulated Gentamicin for Ophthalmic Controlled Delivery
Abdelbary, G., & El-gendy, N. (2008) · AAPS PharmSciTech · doi:10.1208/s12249-008-9105-1 · Cited by 333
Ghate, D., & Edelhauser, H. F. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.2.275 · Cited by 329
Nanoemulsion as a Potential Ophthalmic Delivery System for Dorzolamide Hydrochloride
Ammar, H. O., Salama, H. A., Ghorab, M., & Mahmoud, A. A. (2009) · AAPS PharmSciTech · doi:10.1208/s12249-009-9268-4 · Cited by 319
Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery
Jiao, J. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.002 · Cited by 314
Nanocarriers for ocular drug delivery: current status and translational opportunity
Gorantla, S., Rapalli, V. K., Waghule, T., Singh, P. P., Dubey, S. K., Saha, R. N., & Singhvi, G. (2020) · RSC Advances · doi:10.1039/d0ra04971a · Cited by 313
Effects of Cyclodextrins on Drug Delivery Through Biological Membranes
Loftsson, T., Vogensen, S. B., Brewster, M. E., & Konráðsdóttir, F. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20992 · Cited by 302
Hyaluronic acid in ocular drug delivery
Zhang, X., Wei, D., Xu, Y., & Zhu, Q. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.118006 · Cited by 196
Advances in ophthalmic drug delivery
Morrison, P. W., & Khutoryanskiy, V. V. (2014) · Therapeutic Delivery · doi:10.4155/tde.14.75 · Cited by 196
Younes, N. F., Abdel-Halim, S. A., & Elassasy, A. I. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1497107 · Cited by 81
Micelles: promising ocular drug carriers for anterior and posterior segment diseases
Durgun, M. E., Güngör, S., & Özsoy, Y. (2020) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2019.0109 · Cited by 67
“72 Dexamethasone (DEX) is an active ingredient that is used in ocular inflammations and is an eye drops solution.”
InfluentialAdvanced nanodelivery platforms for topical ophthalmic drug delivery
Gholizadeh, S., Wang, Z., Chen, X., Dana, R., & Annabi, N. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.02.027 · Cited by 65
Liu, R., Liu, Z., Zhang, C., & Zhang, B. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22540 · Cited by 61
Fan, X., Jiang, K., Geng, F., Lu, W., & Wei, G. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114864 · Cited by 33
Metadata
- Authors
- Kaur, I. P., & Smitha, R.
- Venue
- Drug Development and Industrial Pharmacy
- Publisher
- Informa UK Limited
- Published
- 2002-01
- Volume
- 28
- Issue
- 4
- Pages
- 353-369
- ISSN
- 0363-9045 (ISSN-L)
- 1520-5762
- OpenAlex
- W2106839778
- Cited by
- 305
- References
- 70
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.